Document is current
Any future updates will be listed below
-
Authors
Karsan, Nazia https://orcid.org/0000-0002-6946-5637
Goadsby, Peter J. https://orcid.org/0000-0003-3260-5904
-
Funding
Funding for this research was provided by:
National Institute for Health and care research (NIHR203970)
- License Information
-
More Information
Article History
Accepted: 15 April 2024
First Online: 31 May 2024
Declarations
:
: The work had no specific funding. The author (PJG) is funded otherwise by the National Institute for Health and Care Research UK.
: NK nothing to disclose. PJG reports, over the last 36 months, grants from Celgene and Kallyope, and personal fees from Aeon Biopharma, Abbvie, Aurene, CoolTech LLC, Dr Reddy’s, Eli-Lilly and Company, Linpharma, Lundbeck, Pfizer, PureTech Health LLC, Satsuma, Shiratronics, Teva Pharmaceuticals, Tremeau, and Vial, and personal fees for advice through Gerson Lehrman Group, Guidepoint, SAI Med Partners, Vector Metric, and fees for educational materials from CME Outfitters and WebMD, and publishing royalties or fees from Massachusetts Medical Society, Oxford University Press, UptoDate and Wolters Kluwer, and a patent magnetic stimulation for headache (No. WO2016090333 A1) assigned to eNeura without fee.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: NK and PJG wrote sections of the manuscript and reviewed various drafts for accuracy, finally approving the submitted version.
